[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].
D000893:Anti-Inflammatory Agents / Q000032:analysis / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004176:Dipyridamole / Q000032:analysis / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000032:analysis / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000032:analysis / Q000494:pharmacology; D010793:Phthalazines / Q000032:analysis / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011724:Pyridazines / Q000032:analysis / Q000494:pharmacology; D011725:Pyridines / Q000032:analysis / Q000494:pharmacology; D011743:Pyrimidines / Q000032:analysis / Q000494:pharmacology; D011799:Quinazolines / Q000032:analysis / Q000494:pharmacology; D011804:Quinolines / Q000032:analysis / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000032:analysis / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D006571:Heterocyclic Compounds; D007093:Imidazoles; D010793:Phthalazines; D011724:Pyridazines; D011725:Pyridines; D011743:Pyrimidines; D011799:Quinazolines; D011804:Quinolines; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Thrombozytenaggregationshemmer--eine neue Wirkstoffklasse. Teil 2: Chemische und pharmakologische Aspekte einzelner Wirkstoffe.